Month: January 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option...

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their...

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/...

Alternative Credentials Market for Higher Education to Grow by USD 1.84 Billion (2025-2029), Driven by Skills Gap and AI Redefining the Market Landscape – Technavio

NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global alternative credentials market...

error: Content is protected !!